While it has been suggested that T-cell exhaustion signature concurs with a lower risk of relapse and symptom recurrence47, depletion of PD-1+ T cells in established type I diabetes (T1D) and experimental autoimmune encephalomyelitis (EAE) models favorably influences the clinical outcome48. Here, PDCD1 is linked to experimental autoimmune encephalomyelitis.